{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:23:18Z","timestamp":1782843798370,"version":"3.54.5"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","award":["GN2628"],"award-info":[{"award-number":["GN2628"]}],"id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000871","name":"Newlife Foundation for Disabled Children","doi-asserted-by":"publisher","award":["12-13\/11"],"award-info":[{"award-number":["12-13\/11"]}],"id":[{"id":"10.13039\/501100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"RCUK | Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/P007791\/1"],"award-info":[{"award-number":["BB\/P007791\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","award":["PKD_RP_005_20211124"],"award-info":[{"award-number":["PKD_RP_005_20211124"]}],"id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary cilia mediate vertebrate development and growth factor signalling. Defects in primary cilia cause inherited developmental conditions termed ciliopathies. Ciliopathies often present with cystic kidney disease, a major cause of early renal failure. Currently, only one drug, Tolvaptan, is licensed to slow the decline of renal function for the ciliopathy polycystic kidney disease. Novel therapeutic interventions are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We screened clinical development compounds to identify those that reversed cilia loss due to siRNA knockdown. In parallel, we undertook a whole genome siRNA-based reverse genetics phenotypic screen to identify positive modulators of cilia formation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Using a clinical development compound screen, we identify fasudil hydrochloride. Fasudil is a generic, off-patent drug that is a potent, broadly selective Rho-associated coiled-coil-containing protein kinase (ROCK) inhibitor. In parallel, the siRNA screen identifies\n                      <jats:italic>ROCK2<\/jats:italic>\n                      and we demonstrate that ROCK2 is a key mediator of cilium formation and function through its possible effects on actin cytoskeleton remodelling.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results indicate that specific ROCK2 inhibitors (e.g. belumosudil) could be repurposed for cystic kidney disease treatment. We propose that ROCK2 inhibition represents a novel, disease-modifying therapeutic approach for heterogeneous ciliopathies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-025-00847-1","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T03:37:21Z","timestamp":1745033841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Drug and siRNA screens identify ROCK2 as a therapeutic target for ciliopathies"],"prefix":"10.1038","volume":"5","author":[{"given":"Claire E. L.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Streets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6341-8661","authenticated-orcid":false,"given":"Alice V. R.","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4259-7680","authenticated-orcid":false,"given":"Subaashini","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunayna K.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7736-5225","authenticated-orcid":false,"given":"Katarzyna","family":"Szymanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Karwatka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4698-0844","authenticated-orcid":false,"given":"Thomas","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Trowbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma N.","family":"Grellscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2401-7029","authenticated-orcid":false,"given":"Ciaran G.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7227-1614","authenticated-orcid":false,"given":"Georgia","family":"Mavria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7211-5400","authenticated-orcid":false,"given":"Albert C. M.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-8234","authenticated-orcid":false,"given":"Colin A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"847_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.tcb.2016.08.002","volume":"27","author":"JJ Malicki","year":"2017","unstructured":"Malicki, J. J. & Johnson, C. A. The cilium: cellular antenna and central processing unit. Trends Cell. Biol. 27, 126\u2013140 (2017).","journal-title":"Trends Cell. Biol."},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nrm.2017.60","volume":"18","author":"JF Reiter","year":"2017","unstructured":"Reiter, J. F. & Leroux, M. R. Genes and molecular pathways underpinning ciliopathies. Nat. Rev. Mol. Cell Biol. 18, 533\u2013547 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"847_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrg2774","volume":"11","author":"SC Goetz","year":"2010","unstructured":"Goetz, S. C. & Anderson, K. V. The primary cilium: a signalling centre during vertebrate development. Nat. Rev. Genet. 11, 331\u2013344 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"847_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.gde.2009.04.008","volume":"19","author":"MA Lancaster","year":"2009","unstructured":"Lancaster, M. A. & Gleeson, J. G. The primary cilium as a cellular signaling center: lessons from disease. Curr. Opin. Genet. Dev. 19, 220\u2013229 (2009).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"847_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb3109","volume":"17","author":"Q Lu","year":"2015","unstructured":"Lu, Q. et al. Early steps in primary cilium assembly require EHD1\/EHD3-dependent ciliary vesicle formation. Nat. Cell Biol. 17, 228\u2013240 (2015).","journal-title":"Nat. Cell Biol."},{"key":"847_CR6","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMra1010172","volume":"364","author":"F Hildebrandt","year":"2011","unstructured":"Hildebrandt, F., Benzing, T., & Katsanis, N. Ciliopathies. N. Engl. J. Med. 364, 1533\u20131543 (2011).","journal-title":"N. Engl. J. Med."},{"key":"847_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0070-2153(08)00605-4","volume":"84","author":"RJ Quinlan","year":"2008","unstructured":"Quinlan, R. J., Tobin, J. L. & Beales, P. L. Modeling ciliopathies: primary cilia in development and disease. Curr. Top. Dev. Biol. 84, 249\u2013310 (2008).","journal-title":"Curr. Top. Dev. Biol."},{"key":"847_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/ndt\/gfx043","volume":"33","author":"VE Torres","year":"2018","unstructured":"Torres, V. E. et al. Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease, the TEMPO 4:4 Trial. Nephrol. Dial. Transplant. 33, 477\u2013489 (2018).","journal-title":"Nephrol. Dial. Transplant."},{"key":"847_CR9","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","volume":"377","author":"VE Torres","year":"2017","unstructured":"Torres, V. E. et al. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N. Engl. J. Med. 377, 1930\u20131942 (2017).","journal-title":"N. Engl. J. Med."},{"key":"847_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ndt\/gfv456","volume":"31","author":"RT Gansevoort","year":"2016","unstructured":"Gansevoort, R. T. et al. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease, a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrol. Dial. Transplant. 31, 337\u2013348 (2016).","journal-title":"Nephrol. Dial. Transplant."},{"key":"847_CR11","unstructured":"European Medicines Agency. Human Medicine European Public Assessment Report (EPAR): Jinarc. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/jinarc-epar-product-information_en.pdf Accessed 20 December 2024. (2020)."},{"key":"847_CR12","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1172\/JCI99232","volume":"128","author":"YJ Kim","year":"2018","unstructured":"Kim, Y. J. et al. Eupatilin rescues ciliary transition zone defects to ameliorate ciliopathy-related phenotypes. J. Clin. Invest. 128, 3642\u20133648 (2018).","journal-title":"J. Clin. Invest."},{"key":"847_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing, progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"847_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.kint.2020.02.012","volume":"98","author":"M Lannoy","year":"2020","unstructured":"Lannoy, M. et al. The positive effect of selective prostaglandin E2 receptor EP2 and EP4 blockade on cystogenesis in vitro is counteracted by increased kidney inflammation in vivo. Kidney Int. 98, 404\u2013419 (2020).","journal-title":"Kidney Int."},{"key":"847_CR15","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/ncb3201","volume":"17","author":"G Wheway","year":"2015","unstructured":"Wheway, G. et al. An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes. Nat. Cell Biol. 17, 1074\u20131087 (2015).","journal-title":"Nat. Cell Biol."},{"key":"847_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06448-y","volume":"9","author":"A Buskin","year":"2018","unstructured":"Buskin, A. et al. Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa. Nat. Commun. 9, 4234 (2018).","journal-title":"Nat. Commun."},{"key":"847_CR17","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1242\/jcs.186221","volume":"129","author":"OM Daly","year":"2016","unstructured":"Daly, O. M. et al. CEP164-null cells generated by genome editing show a ciliation defect with intact DNA repair capacity. J. Cell Sci. 129, 1769\u20131774 (2016).","journal-title":"J. Cell Sci."},{"key":"847_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 9, 676\u2013682 (2012).","journal-title":"Nat. Methods."},{"key":"847_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nmeth.1351","volume":"6","author":"A Birmingham","year":"2009","unstructured":"Birmingham, A. et al. Statistical methods for analysis of high-throughput RNA interference screens. Nat. Methods 6, 569\u2013575 (2009).","journal-title":"Nat. Methods"},{"key":"847_CR20","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ygeno.2006.12.014","volume":"89","author":"XD Zhang","year":"2007","unstructured":"Zhang, X. D. A pair of new statistical parameters for quality control in RNA interference high-throughput screening assays. Genomics 89, 552\u2013561 (2007).","journal-title":"Genomics"},{"key":"847_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/1087057111405851","volume":"16","author":"XD Zhang","year":"2011","unstructured":"Zhang, X. D. Illustration of SSMD, z score, SSMD*, z* score, and t statistic for hit selection in RNAi high-throughput screens. J. Biomol. Screen. 16, 775\u2013785 (2011).","journal-title":"J. Biomol. Screen."},{"key":"847_CR22","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2007.03.053","volume":"129","author":"MV Nachury","year":"2007","unstructured":"Nachury, M. V. et al. A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell 129, 1201\u20131213 (2007).","journal-title":"Cell"},{"key":"847_CR23","doi-asserted-by":"publisher","first-page":"5550","DOI":"10.1073\/pnas.1816747116","volume":"116","author":"LE Weiss","year":"2019","unstructured":"Weiss, L. E., Milenkovic, L., Yoon, J., Stearns, T. & Moerner, W. E. Motional dynamics of single Patched1 molecules in cilia are controlled by Hedgehog and cholesterol. Proc. Natl Acad. Sci. USA 116, 5550\u20135557 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"847_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.omtm.2019.11.016","volume":"17","author":"C Sanjurjo-Soriano","year":"2019","unstructured":"Sanjurjo-Soriano, C. et al. Genome editing in patient iPSCs corrects the most prevalent USH2A mutations and reveals intriguing mutant mRNA expression profiles. Mol. Ther. Methods Clin. Dev. 17, 156\u2013173 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"847_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-6949-4_14","volume":"1597","author":"M Takasato","year":"2017","unstructured":"Takasato, M. & Little, M. H. Making a kidney organoid using the directed differentiation of human pluripotent stem cells. Methods Mol. Biol. 1597, 195\u2013206 (2017).","journal-title":"Methods Mol. Biol."},{"key":"847_CR26","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.kint.2018.05.003","volume":"94","author":"C Borestr\u00f6m","year":"2018","unstructured":"Borestr\u00f6m, C. et al. A CRISP(e)R view on kidney organoids allows generation of an induced pluripotent stem cell-derived kidney model for drug discovery. Kidney Int. 94, 1099\u20131110 (2018).","journal-title":"Kidney Int."},{"key":"847_CR27","doi-asserted-by":"publisher","first-page":"e135385","DOI":"10.1172\/jci.insight.135385","volume":"5","author":"AJ Streets","year":"2020","unstructured":"Streets, A. J., Prosseda, P. P. & Ong, A. C. Polycystin-1 regulates ARHGAP35-dependent centrosomal RhoA activation and ROCK signalling. JCI Insight 5, e135385 (2020).","journal-title":"JCI Insight"},{"key":"847_CR28","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.2715","volume":"45","author":"M Ma","year":"2013","unstructured":"Ma, M. et al. Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease. Nat. Genet. 45, 1004\u20131012 (2013).","journal-title":"Nat. Genet."},{"key":"847_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2176\/nmc.51.679","volume":"51","author":"J Zhao","year":"2011","unstructured":"Zhao, J. et al. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol. Med. Chir. 51, 679\u2013683 (2011).","journal-title":"Neurol. Med. Chir."},{"key":"847_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/chd.12764","volume":"14","author":"H Ruan","year":"2019","unstructured":"Ruan, H., Zhang, Y., Liu, R. & Yang, X. The acute effects of 30\u2009mg vs 60\u2009mg of intravenous Fasudil on patients with congenital heart defects and severe pulmonary arterial hypertension. Congenit. Heart Dis. 14, 645\u2013650 (2019).","journal-title":"Congenit. Heart Dis."},{"key":"847_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jns.2005.06.003","volume":"238","author":"M Shibuya","year":"2005","unstructured":"Shibuya, M., Hirai, S., Seto, M., Satoh, S. & Ohtomo, E. Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J. Neurol. Sci. 238, 31\u201339 (2005).","journal-title":"J. Neurol. Sci."},{"key":"847_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fneur.2020.00173","volume":"11","author":"JC Koch","year":"2020","unstructured":"Koch, J. C. et al. Compassionate use of the ROCK inhibitor fasudil in three patients with amyotrophic lateral sclerosis. Front. Neurol. 11, 173 (2020).","journal-title":"Front. Neurol."},{"key":"847_CR33","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1161\/01.STR.0000181077.84981.11","volume":"36","author":"Y Rikitake","year":"2005","unstructured":"Rikitake, Y. et al. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 36, 2251\u20132257 (2005).","journal-title":"Stroke"},{"key":"847_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejphar.2019.02.009","volume":"850","author":"S Cantoni","year":"2019","unstructured":"Cantoni, S. et al. Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertension. Eur. J. Pharmacol. 850, 126\u2013134 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"847_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/bj3510095","volume":"351","author":"SP Davies","year":"2000","unstructured":"Davies, S. P., Reddy, H., Caivano, M. & Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95\u2013105 (2000).","journal-title":"Biochem. J."},{"key":"847_CR36","unstructured":"Medical Research Council. Kinase Profiling Inhibitor Database. http:\/\/www.kinase-screen.mrc.ac.uk\/kinase-inhibitors. Accessed 20 December 2024."},{"key":"847_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/ICO.0000000000001883","volume":"38","author":"MS Macsai","year":"2019","unstructured":"Macsai, M. S. & Shiloach, M. Use of topical Rho kinase inhibitors in the treatment of Fuchs dystrophy after Descemet stripping only. Cornea 38, 529\u2013534 (2019).","journal-title":"Cornea"},{"key":"847_CR38","doi-asserted-by":"publisher","first-page":"2646904","DOI":"10.1155\/2017\/2646904","volume":"2017","author":"N Okumura","year":"2017","unstructured":"Okumura, N., Kinoshita, S. & Koizumi, N. Application of Rho kinase inhibitors for the treatment of corneal endothelial diseases. J. Ophthalmol. 2017, 2646904 (2017).","journal-title":"J. Ophthalmol."},{"key":"847_CR39","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3109\/02713683.2013.874444","volume":"39","author":"T Isobe","year":"2014","unstructured":"Isobe, T. et al. Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits. Curr. Eye Res. 39, 813\u2013822 (2014).","journal-title":"Curr. Eye Res."},{"key":"847_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7781","volume":"6","author":"J Kim","year":"2015","unstructured":"Kim, J. et al. Actin remodelling factors control ciliogenesis by regulating YAP\/TAZ activity and vesicle trafficking. Nat. Commun. 6, 6781 (2015).","journal-title":"Nat. Commun."},{"key":"847_CR41","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1091\/mbc.E18-02-0088","volume":"29","author":"SJ Copeland","year":"2018","unstructured":"Copeland, S. J., McRae, A., Guarguaglini, G., Trinkle-Mulcahy, L. & Copeland, J. W. Actin-dependent regulation of cilia length by the inverted formin FHDC1. Mol. Biol. Cell 29, 1611\u20131627 (2018).","journal-title":"Mol. Biol. Cell"},{"key":"847_CR42","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1083\/jcb.201202126","volume":"199","author":"KN Schmidt","year":"2012","unstructured":"Schmidt, K. N. et al. Cep164 mediates vesicular docking to the mother centriole during early steps of ciliogenesis. J. Cell. Biol. 199, 1083\u20131101 (2012).","journal-title":"J. Cell. Biol."},{"key":"847_CR43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1083\/jcb.200703047","volume":"178","author":"S Yoshimura","year":"2007","unstructured":"Yoshimura, S. et al. Functional dissection of Rab GTPases involved in primary cilium formation. J. Cell. Biol. 178, 363\u2013369 (2007).","journal-title":"J. Cell. Biol."},{"key":"847_CR44","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1073\/pnas.1018823108","volume":"108","author":"CJ Westlake","year":"2011","unstructured":"Westlake, C. J. et al. Primary cilia membrane assembly is initiated by Rab11 and transport protein particle II (TRAPPII) complex-dependent trafficking of Rabin8 to the centrosome. Proc. Natl Acad. Sci. USA 108, 2759\u20132764 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"847_CR45","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nature04117","volume":"437","author":"KC Corbit","year":"2005","unstructured":"Corbit, K. C. et al. Vertebrate Smoothened functions at the primary cilium. Nature 437, 1018\u20131021 (2005).","journal-title":"Nature"},{"key":"847_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.10","volume":"4","author":"J Shi","year":"2013","unstructured":"Shi, J. et al. Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment. Cell Death Dis. 4, e483 (2013).","journal-title":"Cell Death Dis."},{"key":"847_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1083\/jcb.201504046","volume":"210","author":"KA Newell-Litwa","year":"2015","unstructured":"Newell-Litwa, K. A. et al. ROCK1 and 2 differentially regulate actomyosin organization to drive cell and synaptic polarity. J. Cell Biol. 210, 225\u2013242 (2015).","journal-title":"J. Cell Biol."},{"key":"847_CR48","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1172\/JCI132414","volume":"130","author":"E Ricker","year":"2020","unstructured":"Ricker, E. et al. Serine-threonine kinase ROCK2 regulates germinal center B cell positioning and cholesterol biosynthesis. J. Clin. Invest. 130, 3654\u20133670 (2020).","journal-title":"J. Clin. Invest."},{"key":"847_CR49","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3390\/ijms20061331","volume":"20","author":"Y Takeda","year":"2019","unstructured":"Takeda, Y. et al. ROCK2 regulates monocyte migration and cell to cell adhesion in vascular endothelial cells. Int. J. Mol. Sci. 20, 1331 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"847_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1083\/jcb.201004003","volume":"191","author":"A Pitaval","year":"2010","unstructured":"Pitaval, A., Tseng, Q., Bornens, M. & Th\u00e9ry, M. Cell shape and contractility regulate ciliogenesis in cell cycle-arrested cells. J. Cell Biol. 191, 303\u2013312 (2010).","journal-title":"J. Cell Biol."},{"key":"847_CR51","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1247\/csf.26.677","volume":"26","author":"T Iwasaki","year":"2001","unstructured":"Iwasaki, T., Murata-Hori, M., Ishitobi, S. & Hosoya, H. Diphosphorylated MRLC is required for organization of stress fibers in interphase cells and the contractile ring in dividing cells. Cell Struct. Funct. 26, 677\u2013683 (2001).","journal-title":"Cell Struct. Funct."},{"key":"847_CR52","doi-asserted-by":"publisher","first-page":"622822","DOI":"10.3389\/fcell.2020.622822","volume":"8","author":"CEL Smith","year":"2020","unstructured":"Smith, C. E. L., Lake, A. V. R. & Johnson, C. A. Primary cilia, ciliogenesis and the actin cytoskeleton: a little less resorption, a little more actin please. Front. Cell Dev. Biol. 8, 622822 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"847_CR53","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1016\/j.yexcr.2007.07.002","volume":"313","author":"K Bhadriraju","year":"2007","unstructured":"Bhadriraju, K. et al. Activation of ROCK by RhoA is regulated by cell adhesion, shape, and cytoskeletal tension. Exp. Cell. Res. 313, 3616\u20133623 (2007).","journal-title":"Exp. Cell. Res."},{"key":"847_CR54","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.4161\/cc.24699","volume":"12","author":"J Shi","year":"2013","unstructured":"Shi, J., Surma, M., Zhang, L. & Wei, L. Dissecting the roles of ROCK isoforms in stress-induced cell detachment. Cell Cycle 12, 1492\u20131500 (2013).","journal-title":"Cell Cycle"},{"key":"847_CR55","first-page":"1855","volume":"125","author":"S Tojkander","year":"2012","unstructured":"Tojkander, S., Gateva, G. & Lappalainen, P. Actin stress fibers-assembly, dynamics and biological roles. J. Cell Sci. 125, 1855\u20131864 (2012).","journal-title":"J. Cell Sci."},{"key":"847_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15321","volume":"8","author":"G Nardone","year":"2017","unstructured":"Nardone, G. et al. YAP regulates cell mechanics by controlling focal adhesion assembly. Nat. Commun. 8, 15321 (2017).","journal-title":"Nat. Commun."},{"key":"847_CR57","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1242\/jcs.114.15.2713","volume":"114","author":"AJ Ridley","year":"2001","unstructured":"Ridley, A. J. Rho GTPases and cell migration. J. Cell Sci. 114, 2713\u20132722 (2001).","journal-title":"J. Cell Sci."},{"key":"847_CR58","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1083\/jcb.140.3.647","volume":"140","author":"T Matsui","year":"1998","unstructured":"Matsui, T. et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin\/radixin\/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140, 647\u2013657 (1998).","journal-title":"J. Cell Biol."},{"key":"847_CR59","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1128\/MCB.16.10.5313","volume":"16","author":"T Leung","year":"1996","unstructured":"Leung, T., Chen, X. Q., Manser, E. & Lim, L. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell Biol. 16, 5313\u20135327 (1996).","journal-title":"Mol. Cell Biol."},{"key":"847_CR60","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1083\/jcb.200411179","volume":"168","author":"Y Shimizu","year":"2005","unstructured":"Shimizu, Y. et al. ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. J. Cell Biol. 168, 941\u2013953 (2005).","journal-title":"J. Cell Biol."},{"key":"847_CR61","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1128\/MCB.23.14.5043-5055.2003","volume":"23","author":"D Thumkeo","year":"2003","unstructured":"Thumkeo, D. et al. Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death. Mol. Cell Biol. 23, 5043\u20135055 (2003).","journal-title":"Mol. Cell Biol."},{"key":"847_CR62","doi-asserted-by":"publisher","first-page":"23022","DOI":"10.1074\/jbc.271.38.23022","volume":"271","author":"K Fujisawa","year":"1996","unstructured":"Fujisawa, K., Fujita, A., Ishizaki, T., Saito, Y. & Narumiya, S. Identification of the Rho-binding domain of p160ROCK, a Rho-associated coiled-coil containing protein kinase. J. Biol. Chem. 271, 23022\u201323028 (1996).","journal-title":"J. Biol. Chem."},{"key":"847_CR63","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-5793(96)00811-3","volume":"392","author":"O Nakagawa","year":"1996","unstructured":"Nakagawa, O. et al. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine\/threonine kinase in mice. FEBS Lett. 392, 189\u2013193 (1996).","journal-title":"FEBS Lett."},{"key":"847_CR64","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/geno.1998.5344","volume":"55","author":"N Takahashi","year":"1999","unstructured":"Takahashi, N., Tuiki, H., Saya, H. & Kaibuchi, K. Localization of the gene coding for ROCK II\/Rho kinase on human chromosome 2p24. Genomics 55, 235\u2013237 (1999).","journal-title":"Genomics"},{"key":"847_CR65","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1083\/jcb.200412043","volume":"170","author":"A Yoneda","year":"2005","unstructured":"Yoneda, A., Multhaupt, H. A. & Couchman, J. R. The Rho kinases I and II regulate different aspects of myosin II activity. J. Cell. Biol. 170, 443\u2013453 (2005).","journal-title":"J. Cell. Biol."},{"key":"847_CR66","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1242\/jcs.170068","volume":"128","author":"R Zaidel-Bar","year":"2015","unstructured":"Zaidel-Bar, R., Zhenhuan, G. & Luxenburg, C. The contractome-a systems view of actomyosin contractility in non-muscle cells. J. Cell Sci. 128, 2209\u20132217 (2015).","journal-title":"J. Cell Sci."},{"key":"847_CR67","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nrm2786","volume":"10","author":"M Vicente-Manzanares","year":"2009","unstructured":"Vicente-Manzanares, M., Ma, X., Adelstein, R. S. & Horwitz, A. R. Non-muscle myosin II takes centre stage in cell adhesion and migration. Nat. Rev. Mol. Cell Biol. 10, 778\u2013790 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"847_CR68","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/nature08895","volume":"464","author":"J Kim","year":"2010","unstructured":"Kim, J. et al. Functional genomic screen for modulators of ciliogenesis and cilium length. Nature 464, 1048\u20131051 (2010).","journal-title":"Nature"},{"key":"847_CR69","doi-asserted-by":"publisher","first-page":"e114087","DOI":"10.1371\/journal.pone.0114087","volume":"9","author":"Y Rao","year":"2014","unstructured":"Rao, Y., Hao, R., Wang, B. & Yao, T. P. A Mec17-myosin II effector axis coordinates microtubule acetylation and actin dynamics to control primary cilium biogenesis. PLoS ONE 9, e114087 (2014).","journal-title":"PLoS ONE"},{"key":"847_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.yexcr.2012.08.009","volume":"319","author":"X Yan","year":"2013","unstructured":"Yan, X. & Zhu, X. Branched F-actin as a negative regulator of cilia formation. Exp. Cell Res. 319, 147\u2013151 (2013).","journal-title":"Exp. Cell Res."},{"key":"847_CR71","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3171\/jns.1986.65.1.0080","volume":"65","author":"M Takayasu","year":"1986","unstructured":"Takayasu, M. et al. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J. Neurosurg. 65, 80\u201385 (1986).","journal-title":"J. Neurosurg."},{"key":"847_CR72","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","volume":"59","author":"Y Feng","year":"2016","unstructured":"Feng, Y., LoGrasso, P. V., Defert, O. & Li, R. Rho kinase (ROCK) inhibitors and their therapeutic potential. J. Med. Chem. 59, 2269\u20132300 (2016).","journal-title":"J. Med. Chem."},{"key":"847_CR73","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1016\/j.bmcl.2014.09.002","volume":"24","author":"D Shaw","year":"2014","unstructured":"Shaw, D. et al. Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension. Bioorg. Med. Chem. Lett. 24, 4812\u20134817 (2014).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"847_CR74","first-page":"158","volume":"46","author":"V Shifrin","year":"2005","unstructured":"Shifrin, V. et al. Effects of SLx-2119, a novel small molecule inhibitor of Rho-associated kinase ROCK (ROK), on growth of human tumor xenografts in nude mice. Proc. Am. Assoc. Cancer Res. 46, 158 (2005).","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"847_CR75","unstructured":"Bartolozzi, A. et al. Pharmacokinetically improved compounds. Patent WO\/2006\/105081 (2006)."},{"key":"847_CR76","unstructured":"Bankston, D. et al. Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof. Patent WO\/2004\/029045 (2004)."},{"key":"847_CR77","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/13543776.2017.1272579","volume":"27","author":"O Defert","year":"2017","unstructured":"Defert, O. & Boland, S. Rho kinase inhibitors: a patent review (2014 - 2016). Expert Opin. Ther. Pat. 27, 507\u2013515 (2017).","journal-title":"Expert Opin. Ther. Pat."},{"key":"847_CR78","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1182\/blood.2021012021","volume":"138","author":"C Cutler","year":"2021","unstructured":"Cutler, C. et al. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Blood 138, 2278\u20132289 (2021).","journal-title":"Blood"},{"key":"847_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/srep03545","volume":"3","author":"RJ McMurray","year":"2013","unstructured":"McMurray, R. J., Wann, A. K., Thompson, C. L., Connelly, J. T. & Knight, M. M. Surface topography regulates wnt signaling through control of primary cilia structure in mesenchymal stem cells. Sci. Rep. 3, 3545 (2013).","journal-title":"Sci. Rep."},{"key":"847_CR80","doi-asserted-by":"publisher","first-page":"e1005785","DOI":"10.1371\/journal.pgen.1005785","volume":"12","author":"K Stewart","year":"2016","unstructured":"Stewart, K. et al. A point mutation in p190A RhoGAP affects ciliogenesis and leads to glomerulocystic kidney defects. PLoS Genet. 12, e1005785 (2016).","journal-title":"PLoS Genet."},{"key":"847_CR81","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1101\/gad.315127.118","volume":"32","author":"J Cai","year":"2018","unstructured":"Cai, J. et al. A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease. Genes Dev. 32, 781\u2013793 (2018).","journal-title":"Genes Dev."},{"key":"847_CR82","first-page":"2398","volume":"39","author":"A Andreu-Cervera","year":"2019","unstructured":"Andreu-Cervera, A. et al. The ciliopathy gene Ftm\/Rpgrip1l controls mouse forebrain patterning via region-specific modulation of hedgehog\/Gli signaling. J. Neurosci. 39, 2398\u20132415 (2019).","journal-title":"J. Neurosci."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00847-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T05:02:08Z","timestamp":1745038928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00847-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00847-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.26.393801","asserted-by":"object"}]},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}